Literature DB >> 33435662

Minilaparoscopy in gynecology: applications, benefits and limitations.

Jvan Casarin1, Chiara Cimmino2, Valeria Artuso2, Antonella Cromi2, Fabio Ghezzi2.   

Abstract

The word "minilaparoscopy" refers to laparoscopic surgical procedures performed using <5-mm trocars, with the exception of the umbilical access. The aim of this review is to explore the feasibility of minilaparoscopy in gynecologic surgery, focusing on instruments, surgical techniques, application and limits of this approach. In this review the authors discussed the positive features and limitation of 3-mm laparoscopy for gynecologic surgery. Using smaller trocars decreases incisional and postoperative pain, and shortens hospitalization, and provides a better cosmetic outcome. Transvaginal specimen extraction can be used to maximize the aesthetic outcomes. A minilaparoscopic surgical procedure is accomplished with lower carbon dioxide pressures, reducing pneumoperitoneum related complications. Accurate patient selection is critical in order to offer the best laparoscopic approach, considering that obesity and endometriosis may represent a challenge for 3-mm surgical tools, which are more flexible and have lower grasping ability. Minilaparoscopy has been shown as a valid alternative to conventional laparoscopy both for diagnostic purpose, major surgical procedures and oncological surgery. Minilaparoscopy in gynecologic surgery represents an option for selected patients, for both benign and malignant indications. The aesthetic outcome represents the main benefit of this approach. Surgeons must be aware of few limitations of this technique such as severe obesity and endometriosis.

Entities:  

Mesh:

Year:  2021        PMID: 33435662     DOI: 10.23736/S2724-606X.20.04753-X

Source DB:  PubMed          Journal:  Minerva Obstet Gynecol        ISSN: 2724-606X


  1 in total

1.  Total Hysterectomy by Low-Impact Laparoscopy to Decrease Opioids Consumption: A Prospective Cohort Study.

Authors:  Yohann Dabi; Samia Ouasti; Hélène Didelot; Henri Wohrer; Dounia Skalli; Gregoire Miailhe; Jennifer Uzan; Clément Ferrier; Sofiane Bendifallah; Bassam Haddad; Emile Daraï; Cyril Touboul
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.